MeSH tree: D27.505.519.389
Researchers at the University of Tartu showed that large language models can identify with high accuracy why patients stop using antidiabetic medications or statins based on doctors' electronic clinical notes. The study opens ...
7 hours ago
0
1
The benefits of dietary fiber extend beyond digestive health, as dietary fiber-derived metabolites produced by gut microbiota can influence immune function. Short-chain fatty acids (SCFAs) are secondary metabolites produced ...
Jun 22, 2026
0
3
The Cancer Metabolism and Tumor Microenvironment Laboratory at the University of Liège has uncovered a previously unrecognized mechanism that promotes cancer cell survival under therapeutic pressure. Published in MedComm, ...
Jun 22, 2026
0
2
A research team from the Germans Trias i Pujol Research Institute (IGTP) has developed a new experimental model based on induced pluripotent stem cells (iPSCs) that makes it possible to reproduce in the laboratory the progression ...
Jun 22, 2026
0
4
Cholesterol-reducing statin medications to lower the risk of heart attack and stroke; personalized cancer therapies; mRNA technologies that revolutionized vaccine development and are now transforming cancer therapy. These ...
Jun 22, 2026
0
2
When a patient has made it to 85 years old in reasonable health, their instinct—and often their physician's—is to redouble prevention efforts, optimize every number and close every gap. I want to argue the opposite.
Jun 15, 2026
0
11
What if a new combination of cancer drugs could sound an alarm, alerting the body's immune system to invoke a targeted response to cancer cells? Findings from a new study appear in a paper published in Nucleic Acids Research.
Jun 11, 2026
0
6
Researchers at Mass General Brigham have demonstrated that older U.S. veterans who initiated statin therapy were significantly less likely to develop frailty over time, suggesting that the cholesterol-lowering medications ...
Jun 9, 2026
0
10
Researchers at Baylor College of Medicine and collaborating institutions are challenging the traditional understanding of how cancer drugs called histone deacetylase (HDAC) inhibitors function. For decades, scientists believed ...
Jun 7, 2026
0
16
Researchers at the Icahn School of Medicine at Mount Sinai have identified a previously hidden druggable site in a cancer-related protein that could open the door toward the development of a new generation of more precise ...
Jun 3, 2026
0
9
